✦ LIBER ✦

615 POSTER Safety, tolerability and efficacy of the addition of bevacizumab to oxaliplatin/fluoropyrimidine regimens as first-line treatment of metastatic colorectal cancer (mCRC): Results of TREE 2 cohort of the TREE study

Book ID: 118623192
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 131 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)80911-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Oxaliplatin and F

Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

✍ Hochster, H. S.; Hart, L. L.; Ramanathan, R. K.; Childs, B. H.; Hainsworth, J. D 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 149 KB

601 ORAL Infusional 5-fluorouracil/folin

601 ORAL Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

3063 POSTER Capecitabine (C), in combina

3063 POSTER Capecitabine (C), in combination with irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.)

✍ S. Bursi; G. Masi; F. Loupakis; A. Antonuzzo; S. Chiara; E. Pfanner; I. Petrini; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

6113 POSTER Efficacy and Safety at 12 Mo

6113 POSTER Efficacy and Safety at 12 Months of 1st Line Bevacizumab (Bv) Plus Chemotherapy (CT) in Elderly Patients (Pt) With Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice – the CONCERT French Observational Cohort Study

✍ Bennouna, J.; Phelip, J.M.; Andrée, T.; Asselain, B.; Senellart, H.; Morsli, O.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

6137 POSTER Biological Analysis of Phase

6137 POSTER Biological Analysis of Phase II Study Evaluating the Activity of Cetuximab Combined to Oxaliplatin and Fluoropirimidine (TEGAFOX-E) as First Line Treatment in Metastatic Colorectal Cancer (mCRC) Pts by the Italian Trials in Medical Oncology (I.T.M.O.) Group

✍ Bartolomeo, M. Pi; Dotti, K.F.; Pietrantonio, F.; Perrone, F.; Martinetti, A.; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A Phase 2b, Double-Blind, Randomized Stu

A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB